Study of Anticataractogenic activity of Drishti Eye drop

The clinical evaluation of anti-cataractogenic effect of an Ayurvedic eye drop

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/01/003324

Enrollment

400

Registered

2013-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cataract problem

Interventions

Intervention1: Ayurvedic Dristi eye drop,: one drop twice in a day till 12 months. Control Intervention1: no: no treatment

Eligibility

Inclusion criteria

Inclusion criteria: Early cataract,grade 1and grade II, without any systemic or metabolic disease

Exclusion criteria

Exclusion criteria: Major Lid abnormality Corneal pathology or Opacity Glaucoma Uvitis Retinal or macular diseases Dibeties mellitus and other congenital defects

Design outcomes

Primary

Measure	Time frame
Varification of Anticataractogenic effectTimepoint: 1 years	—

Secondary

Measure	Time frame
Any other change in eye or any subjective feeling will be recorded to studyTimepoint: 1 year	—

Countries

India

Contacts

Public ContactDr V B Pratap

drvbpratap@rediffmail.com05862242884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026